Cargando…
Aberrant glycosylation associated with enzymes as cancer biomarkers
BACKGROUND: One of the new roles for enzymes in personalized medicine builds on a rational approach to cancer biomarker discovery using enzyme-associated aberrant glycosylation. A hallmark of cancer, aberrant glycosylation is associated with differential expressions of enzymes such as glycosyltransf...
Autores principales: | Meany, Danni L, Chan, Daniel W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170274/ https://www.ncbi.nlm.nih.gov/pubmed/21906357 http://dx.doi.org/10.1186/1559-0275-8-7 |
Ejemplares similares
-
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
por: Tuccillo, Franca Maria, et al.
Publicado: (2014) -
Role of aberrant glycosylation enzymes in oral cancer progression
por: Vajaria, Bhairavi N., et al.
Publicado: (2018) -
Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017) -
Involvement of Aberrant Glycosylation in Thyroid Cancer
por: Miyoshi, Eiji, et al.
Publicado: (2010) -
Drug resistance related to aberrant glycosylation in colorectal cancer
por: Very, Ninon, et al.
Publicado: (2017)